Buy IDRA-21 Powder For Sale Online

Chemical Components and Synonyms

IDRA-21 Powder:
IUPAC Name: 7-chloro-3-methyl-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide
Common Synonyms: IDRA-21

CAS Number

IDRA-21: 22503-72-6

Molecular Formula and Structure

IDRA-21:
Molecular Formula: C8H9ClN2O2S
Structural Diagram:

    Cl
     |
  C6H3N2SO2CH3

Purity and Grade

Purity: ≥ 98%
Grade: Research Grade

Physical and Chemical Properties

• Form: Powder
• Melting Point: Approximately 165-168°C
• Boiling Point: Not typically applicable for solid research chemicals
• Solubility: Soluble in organic solvents like DMSO and ethanol
• Density: Not readily available
• Molecular Weight: Approximately 232.69 g/mol

Safety and Handling Information

• Hazard Symbols: ⚠️
• Precautionary Statements:
  • Avoid inhalation, ingestion, and contact with skin and eyes outside of research protocols.
  • Use personal protective equipment (PPE) such as gloves and safety goggles during handling in a research setting.
• First-Aid Measures:
  • If inhaled, move to fresh air and seek medical attention if necessary.
  • In case of skin contact, rinse with plenty of water and soap.
  • If ingested in a non-research context, seek immediate medical help.

Usage and Applications

IDRA-21 Powder is primarily used in research to investigate its effects on cognitive enhancement and synaptic plasticity. Studies may focus on its impact on AMPA receptors, memory, learning, and potential therapeutic applications for cognitive disorders.

Storage Conditions

Store in a cool, dry place away from direct sunlight. Keep the container tightly closed and store at room temperature.

Regulatory Information

This product complies with international chemical safety standards. Researchers must ensure compliance with local regulations concerning the use of IDRA-21 in their studies.

Shipping Information

Clients are responsible for verifying the legal status of IDRA-21 in their country before purchasing. Our packaging meets industry standards to ensure safe delivery, and we offer various shipping options for your convenience.

Technical Support and Contact Information

For any questions or technical support, please visit our Contact Us page.

FAQ

1. What is the form of IDRA-21 in this product?

IDRA-21 is provided in powder form, suitable for precise measurement in research applications.

2. What are the typical applications of IDRA-21 Powder?

It is used in research to study cognitive enhancement, synaptic plasticity, and AMPA receptor modulation.

3. How should I store IDRA-21 Powder?

Store it in a cool, dry place away from direct sunlight, at room temperature.

4. Are there any shipping restrictions for IDRA-21 Powder?

Yes, clients must verify the legal status of IDRA-21 in their country before purchasing.

5. Who do I contact if I have questions about IDRA-21 Powder?

For any inquiries, please visit our Contact Us page for assistance.

IDRA-21 Powder

Introduction

IDRA-21 is a potent nootropic compound belonging to the benzothiadiazine family. It is primarily recognized for its cognitive-enhancing properties, particularly in improving memory and learning capabilities. As a positive allosteric modulator of the AMPA receptor, IDRA-21 has garnered attention for its potential in treating cognitive deficits and enhancing synaptic plasticity. This article provides a comprehensive overview of IDRA-21 powder, including its chemical properties, pharmacology, potential health benefits, dosage guidelines, safety considerations, and research applications.

Chemical Properties

• IUPAC Name: 7-chloro-3-(2-oxo-1,3-benzothiazol-3(2H)-yl)benzo[d]thiazol-2(3H)-one
• Molecular Formula: C8H9ClN2O2S
• Molecular Weight: 232.69 g/mol
• Chemical Structure: IDRA-21’s structure is characterized by the presence of a benzothiadiazine ring, contributing to its unique pharmacological profile.

Pharmacology

IDRA-21’s cognitive-enhancing effects are mediated through its interaction with the AMPA receptor, a subtype of glutamate receptor critical for fast synaptic transmission and plasticity in the central nervous system.

• Mechanism of Action: IDRA-21 functions as a positive allosteric modulator of the AMPA receptor, enhancing synaptic transmission and promoting long-term potentiation (LTP). This modulation leads to improved synaptic plasticity, which is essential for memory formation and learning processes.
• Potential Effects: Research suggests that IDRA-21 can improve cognitive function, enhance memory and learning, and potentially counteract cognitive deficits associated with various neurological conditions.

Health Benefits

IDRA-21 powder offers a range of potential health benefits, including:

• Cognitive Enhancement: IDRA-21 is renowned for its ability to improve cognitive functions such as memory, learning, and overall mental performance. It is often used by individuals seeking to enhance their cognitive capabilities.
• Memory Improvement: IDRA-21 may enhance memory formation and retrieval, making it beneficial for individuals experiencing memory decline or those seeking to boost their retention capabilities.
• Neuroprotection: IDRA-21 may provide neuroprotective benefits by supporting the health and function of neurons, potentially reducing the risk of neurodegenerative diseases.
• Potential Treatment for Cognitive Deficits: IDRA-21 has been studied for its potential to mitigate cognitive deficits associated with conditions such as Alzheimer’s disease, schizophrenia, and traumatic brain injury.

Dosage and Administration

• Powder Dosage: The recommended dosage of IDRA-21 powder typically ranges from 3mg to 10mg per day. It is crucial to start with a lower dose to assess tolerance and effectiveness.
• Administration: IDRA-21 powder can be dissolved in water or another beverage for oral consumption. Accurate measurement using a milligram scale is essential to ensure proper dosing.

Safety and Considerations

While IDRA-21 is generally well-tolerated, some individuals may experience side effects such as headache, nausea, irritability, or insomnia. It is important to consult with a healthcare provider before beginning supplementation, especially for individuals with pre-existing medical conditions or those taking other medications. Long-term use and high dosages should be approached with caution to avoid potential adverse effects.

Research Applications

IDRA-21 continues to be a subject of extensive research, with studies exploring its potential benefits in various domains, including:

• Cognitive Enhancement: Investigating the effects of IDRA-21 on memory, learning, and overall cognitive function in healthy individuals and those with cognitive impairments.
• Neuroprotection: Researching its impact on neuronal health and its potential role in preventing or mitigating neurodegenerative diseases such as Alzheimer’s disease and Parkinson’s disease.
• Traumatic Brain Injury (TBI): Exploring its potential benefits for individuals recovering from TBI, with a focus on enhancing cognitive function and promoting neurorepair.
• Schizophrenia and Cognitive Deficits: Examining its potential benefits for individuals with schizophrenia and other conditions characterized by cognitive deficits.

Conclusion

IDRA-21 powder offers a versatile and potent means of harnessing the cognitive-enhancing benefits of this unique nootropic. Its potential to improve memory, enhance learning, and provide neuroprotective benefits makes it a valuable supplement for individuals seeking to optimize their cognitive performance.